We understand the physical and emotional toll that psoriatic arthritis (PsA) can take on the lives of everyone it touches.That’s why we’ve designed a place to help you take control of your disease and your life. A central hub with the information you need. With the right tools, there are no limits to what you can achieve. Because every day should be filled with triumphs, no matter how big or small they may be.
Why do you have PsA?

Find out what causes PsA, whether there may be a genetic link, and if there’s anything else you should watch out for.

Are depression and PsA linked?

You’re twice as likely to suffer from depression if you have PsA than if you only have psoriasis – find out how to handle it.

Do you have to see a doctor in person?

With COVID-19 part of all our lives, you might not always need to see your doctor in the flesh.

How can you tell if your treatment is working?

Use our handy tracker to keep on top of how you’re feeling, so your doctor knows whether your treatment is working.

PsA vs Pso

What’s the difference between psoriatic arthritis and psoriasis?

How to get moving

Exercise could help you manage your psoriatic arthritis.

How to meet people with PsA

You’re not alone – there are other patients with psoriatic arthritis, just like you out there.

Dealing with symptoms

Advice about dealing with the main PsA symptoms.

FAQs
Get quick questions to the most common questions about
psoriatic arthritis.

المراجع

Ysrraelit MC, Fiol MP, Gaitán MI, Correale J. Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists. Front Neurol. 2018; 8: 729. Published 2018 Jan 11.doi:10.3389/fneur.2017.00729.
Mortensen G, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient Prefer Adherence. 2017; 11: 1789-1796. Published 2017 Oct 19. doi:10.2147/PPA.S142373.
Parker LS, Topcu G, De Boos D, et al. (2020). The notion of “invisibility” in people’s experiences of the symptoms of multiple sclerosis: a systematic meta-synthesis.
Green R, Cutter G, Friendly M, et al. Which symptoms contribute the most to patients’ perception of health in multiple sclerosis? Multiple Scler J Exp Transl Clin. 2017; 3(3): 1–6.
de Sa JC, Airas L, Bartholome E, et al. Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord. 2011; 4(3): 139-168. doi:10.1177/1756285611403646.
National MS Society/ Symptoms and Diagnosis/MS Symptoms. Accessed June 29, 2020. https://www.nationalmssociety.... Symptoms and Diagnosis/MS Symptoms.
Mortensen G, Rasmussen PV. The impact of quality of life on treatment preferences in multiple sclerosis patients. Patient Prefer Adherence. 2017; 11: 1789-1796. Published 2017 Oct 19. doi:10.2147/PPA.S142373.
Green R, Cutter G, Friendly M, et al. Which symptoms contribute the most to patients’ perception of health in multiple sclerosis? Multiple Scler J Exp Transl Clin. 2017; 3(3): 1–6.
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson